| Dr Christopher M Belletieri, DO | |
|
3554 Hulmeville Rd., Suite 103, Bensalem, PA 19020 | |
| (215) 633-1750 | |
| (215) 633-1753 |
| Full Name | Dr Christopher M Belletieri |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 3554 Hulmeville Rd., Bensalem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174562904 | NPI | - | NPPES |
| 0373708000 | Other | PA | IBC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS009483L (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dedicated Doctors Pc | 0446495600 | 2 |
| Bmc Primary Care Physicians Llc | 1355585159 | 5 |
| Genmed Llc | 6709262793 | 7 |
News Archive
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
Galderma, a global healthcare company focused on skin health, announced today that it has received U.S. Food and Drug Administration approval to market Restylane Lyft for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.
Pfizer Inc. announced today that the United States Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer's clinical data package for tafamidis meglumine.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the Heidelberg University Hospitals have discovered that pancreatic cancer attracts regulatory T cells, which suppress the activity of immune cells.
› Verified 6 days ago
| Entity Name | Dedicated Doctors Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932459914 PECOS PAC ID: 0446495600 Enrollment ID: O20130319000115 |
News Archive
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
Galderma, a global healthcare company focused on skin health, announced today that it has received U.S. Food and Drug Administration approval to market Restylane Lyft for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.
Pfizer Inc. announced today that the United States Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer's clinical data package for tafamidis meglumine.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the Heidelberg University Hospitals have discovered that pancreatic cancer attracts regulatory T cells, which suppress the activity of immune cells.
› Verified 6 days ago
| Entity Name | Bmc Primary Care Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548509839 PECOS PAC ID: 1355585159 Enrollment ID: O20130918000013 |
News Archive
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
Galderma, a global healthcare company focused on skin health, announced today that it has received U.S. Food and Drug Administration approval to market Restylane Lyft for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.
Pfizer Inc. announced today that the United States Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer's clinical data package for tafamidis meglumine.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the Heidelberg University Hospitals have discovered that pancreatic cancer attracts regulatory T cells, which suppress the activity of immune cells.
› Verified 6 days ago
| Entity Name | Genmed Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306592787 PECOS PAC ID: 6709262793 Enrollment ID: O20220928001816 |
News Archive
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
Galderma, a global healthcare company focused on skin health, announced today that it has received U.S. Food and Drug Administration approval to market Restylane Lyft for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.
Pfizer Inc. announced today that the United States Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer's clinical data package for tafamidis meglumine.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the Heidelberg University Hospitals have discovered that pancreatic cancer attracts regulatory T cells, which suppress the activity of immune cells.
› Verified 6 days ago
| Entity Name | Encompass Remote Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063105559 PECOS PAC ID: 7810358744 Enrollment ID: O20240208000947 |
News Archive
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
Galderma, a global healthcare company focused on skin health, announced today that it has received U.S. Food and Drug Administration approval to market Restylane Lyft for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.
Pfizer Inc. announced today that the United States Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer's clinical data package for tafamidis meglumine.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the Heidelberg University Hospitals have discovered that pancreatic cancer attracts regulatory T cells, which suppress the activity of immune cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher M Belletieri, DO 3554 Hulmeville Rd., Suite 103, Bensalem, PA 19020 Ph: (215) 633-1750 | Dr Christopher M Belletieri, DO 3554 Hulmeville Rd., Suite 103, Bensalem, PA 19020 Ph: (215) 633-1750 |
News Archive
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
Galderma, a global healthcare company focused on skin health, announced today that it has received U.S. Food and Drug Administration approval to market Restylane Lyft for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.
Pfizer Inc. announced today that the United States Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer's clinical data package for tafamidis meglumine.
Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.
Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the Heidelberg University Hospitals have discovered that pancreatic cancer attracts regulatory T cells, which suppress the activity of immune cells.
› Verified 6 days ago
Christine T Wanjeri-hasen, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2966 Street Rd, Bensalem, PA 19020 Phone: 215-638-0666 Fax: 215-638-3320 | |
Dr. Brittania Jennings Lee, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3554 Hulmeville Rd, Suite 103, Bensalem, PA 19020 Phone: 215-757-0465 Fax: 215-757-0546 | |
Dr. Barry E Marged, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2636 Bristol Pike, Bensalem, PA 19020 Phone: 215-639-8770 | |
Val Raymond Cantagallo, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2373 Bristol Rd, Bensalem, PA 19020 Phone: 215-752-1810 Fax: 215-752-1060 | |
Stephen M Thomas, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5000 Bensalem Blvd, Bensalem, PA 19020 Phone: 215-638-4340 Fax: 215-633-9710 | |
Dr. Jessica T Baker, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3237 Bristol Rd Ste 203, Bensalem, PA 19020 Phone: 215-559-9166 Fax: 215-910-4584 |